Abstract
AbstractWe surveyed members of the Emerging Infections Network about Candida auris screening practices at US healthcare facilities. Only 37% of respondents reported conducting screening; among these, 75% reported detection of at least 1 C. auris case in the last year. Increased screening could improve C. auris detection and prevent spread.
Publisher
Cambridge University Press (CUP)
Reference11 articles.
1. 10. Rowlands, J , Dufort, E , Chaturvedi, S , et al. Candida auris admission screening pilot in select units of New York City healthcare facilities, 2017–2019. Am J Infect Control 2023. doi: 10.1016/j.ajic.2023.01.012.
2. The importance of information technology and surveillance to prevent the spread of Candida auris;Parti;Am J Infect Control,2021
3. Factors associated with Candida auris colonization and transmission in skilled nursing facilities with ventilator units, New York, 2016–2018;Rossow;Clin Infect Dis,2021
4. 3. The Environmental Protection Agency (EPA). List P includes EPA-approved products with claims against C. auris (https://www.epa.gov/pesticide-registration/list-p-antimicrobial-products-registered-epa-claims-against-candida-auris).
5. Candida auris in healthcare facilities, New York, USA, 2013–2017;Adams;Emerg Infect Dis,2018